HHLR ADVISORS, LTD. - Q1 2020 holdings

$7.42 Billion is the total value of HHLR ADVISORS, LTD.'s 60 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 22.2% .

 Value Shares↓ Weighting
ZM SellZOOM VIDEO COMMUNICATIONS INcl a$905,131,000
+92.3%
6,194,437
-10.4%
12.20%
+108.1%
IQ  IQIYI INCsponsored ads$831,164,000
-15.7%
46,694,6290.0%11.20%
-8.8%
BGNE  BEIGENE LTDsponsored adr$673,690,000
-25.7%
5,472,2590.0%9.08%
-19.7%
UBER BuyUBER TECHNOLOGIES INC$537,759,000
+16.6%
19,260,700
+24.2%
7.25%
+26.2%
JD  JD COM INCspon adr cl a$482,154,000
+15.0%
11,905,0280.0%6.50%
+24.4%
TAL SellTAL EDUCATION GROUPsponsored ads$399,744,000
-27.7%
7,505,520
-34.5%
5.39%
-21.8%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$385,015,000
-8.3%
1,979,7160.0%5.19%
-0.8%
PDD  PINDUODUO INCsponsored ads$314,519,000
-4.7%
8,729,3660.0%4.24%
+3.1%
CBPO  CHINA BIOLOGIC PRODS HLDGS I$296,937,000
-7.3%
2,751,2000.0%4.00%
+0.3%
ESGR  ENSTAR GROUP LIMITED$277,994,000
-23.1%
1,747,8400.0%3.75%
-16.8%
BILI  BILIBILI INCspons ads rep z$239,244,000
+25.8%
10,215,3550.0%3.22%
+36.0%
ALGN SellALIGN TECHNOLOGY INC$185,527,000
-71.8%
1,066,551
-54.7%
2.50%
-69.4%
VIE  VIELA BIO INC$174,465,000
+40.0%
4,591,1760.0%2.35%
+51.4%
FGEN  FIBROGEN INC$137,464,000
-19.0%
3,955,7870.0%1.85%
-12.3%
BBIO BuyBRIDGEBIO PHARMA INC$136,637,000
-11.2%
4,711,604
+7.4%
1.84%
-3.9%
APLS BuyAPELLIS PHARMACEUTICALS INC$134,708,000
-6.0%
5,028,289
+7.5%
1.82%
+1.7%
MDLZ  MONDELEZ INTL INCcl a$127,532,000
-9.1%
2,546,5640.0%1.72%
-1.7%
VIPS NewVIPSHOP HLDGS LTDsponsored ads a$109,762,0007,045,054
+100.0%
1.48%
BPMC BuyBLUEPRINT MEDICINES CORP$94,345,000
-21.7%
1,613,294
+7.2%
1.27%
-15.3%
ZTO NewZTO EXPRESS CAYMAN INCsponsored ads a$90,922,0003,433,592
+100.0%
1.22%
CRM NewSALESFORCE COM INC$79,261,000550,500
+100.0%
1.07%
TSLA NewTESLA INC$68,318,000130,378
+100.0%
0.92%
GOSS  GOSSAMER BIO INC$60,002,000
-35.1%
5,911,5410.0%0.81%
-29.7%
SE SellSEA LTDsponsored ads$55,388,000
-68.0%
1,250,000
-70.9%
0.75%
-65.4%
BEAM NewBEAM THERAPEUTICS INC$53,395,0002,966,403
+100.0%
0.72%
SNAP  SNAP INCcl a$53,099,000
-27.2%
4,465,8850.0%0.72%
-21.2%
MYOK  MYOKARDIA INC$45,754,000
-35.7%
975,9870.0%0.62%
-30.4%
LN SellLINE CORPsponsored adr$41,942,000
-23.7%
871,256
-22.3%
0.56%
-17.5%
NXTC  NEXTCURE INC$39,056,000
-34.2%
1,053,5700.0%0.53%
-28.8%
ARVN  ARVINAS INC$34,469,000
-1.9%
855,3080.0%0.46%
+6.2%
GMAB  GENMAB A Ssponsored ads$31,785,000
-5.1%
1,500,0000.0%0.43%
+2.6%
KNSA  KINIKSA PHARMACEUTICALS LTD$29,348,000
+40.0%
1,895,8880.0%0.40%
+51.7%
ZLAB SellZAI LAB LTDadr$28,430,000
-14.3%
552,256
-30.8%
0.38%
-7.3%
MLCO  MELCO RESORTS AND ENTMNT LTDadr$27,253,000
-48.7%
2,197,8500.0%0.37%
-44.6%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$26,824,000
-23.8%
3,985,7970.0%0.36%
-17.4%
IGMS  IGM BIOSCIENCES INC$19,653,000
+47.1%
350,0000.0%0.26%
+59.6%
AKRO  AKERO THERAPEUTICS INC$18,893,000
-4.5%
891,2010.0%0.26%
+3.7%
AMG BuyAFFILIATED MANAGERS GROUP IN$18,135,000
+200.0%
306,643
+329.8%
0.24%
+225.3%
RGNX  REGENXBIO INC$14,765,000
-21.0%
456,0000.0%0.20%
-14.6%
SDC  SMILEDIRECTCLUB INC$13,534,000
-46.6%
2,898,0860.0%0.18%
-42.4%
NVDA NewNVIDIA CORP$13,180,00050,000
+100.0%
0.18%
MOGU  MOGU INCspon ads$11,962,000
-49.8%
10,446,9700.0%0.16%
-45.8%
UXIN  UXIN LTDads$11,156,000
-31.9%
7,244,3410.0%0.15%
-26.5%
RCUS  ARCUS BIOSCIENCES INC$10,648,000
+37.4%
767,1280.0%0.14%
+48.5%
GTHX  G1 THERAPEUTICS INC$10,463,000
-58.3%
949,4310.0%0.14%
-55.0%
CJJD  CHINA JO-JO DRUGSTORES INC$8,760,000
-0.6%
4,840,0000.0%0.12%
+7.3%
EIDX  EIDOS THERAPEUTICS INC$8,750,000
-14.6%
178,6000.0%0.12%
-7.8%
HOOK  HOOKIPA PHARMA INC$7,782,000
-32.5%
943,2540.0%0.10%
-27.1%
MRUS  MERUS N V$7,260,000
-14.1%
600,0000.0%0.10%
-6.7%
GRUB NewGRUBHUB INC$6,899,000169,386
+100.0%
0.09%
ARGX  ARGENX SEsponsored adr$6,587,000
-17.9%
50,0000.0%0.09%
-11.0%
SOHU  SOHU COM LTDsponsored ads$4,997,000
-44.3%
802,0340.0%0.07%
-40.2%
TXG  10X GENOMICS INC$4,674,000
-18.3%
75,0000.0%0.06%
-11.3%
PASG NewPASSAGE BIO INC$3,947,000250,616
+100.0%
0.05%
CBMG  CELLULAR BIOMEDICINE GROUP I$3,721,000
-2.6%
235,2140.0%0.05%
+4.2%
TCRR  TCR2 THERAPEUTICS INC$2,499,000
-45.8%
322,9030.0%0.03%
-40.4%
CVET NewCOVETRUS INC$1,263,000155,124
+100.0%
0.02%
NEW  PUXIN LTDads$540,000
-47.8%
126,1450.0%0.01%
-46.2%
CIH  CHINA INDEX HLDGS LTDspnsrd ads a$405,000
-62.9%
300,0000.0%0.01%
-64.3%
SFUN  FANG HLDGS LTDadr new$405,000
-52.8%
300,0000.0%0.01%
-54.5%
QCOM ExitQUALCOMM INC$0-200,000
-100.0%
-0.22%
NFLX ExitNETFLIX INC$0-136,400
-100.0%
-0.55%
EDU ExitNEW ORIENTAL ED & TECH GRP Ispon adr$0-603,208
-100.0%
-0.91%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings